BR112014002404A2 - oligonucleotídeo, iniciador, par de iniciadores, sonda, kit, métodos para determinar se o gene prame é expressado em uma amostra biológica, de diagnose de paciente, para determinar a presença ou ausência de tecido de tumor positive, e de tratamento de um paciente, e, composição - Google Patents
oligonucleotídeo, iniciador, par de iniciadores, sonda, kit, métodos para determinar se o gene prame é expressado em uma amostra biológica, de diagnose de paciente, para determinar a presença ou ausência de tecido de tumor positive, e de tratamento de um paciente, e, composiçãoInfo
- Publication number
- BR112014002404A2 BR112014002404A2 BR112014002404A BR112014002404A BR112014002404A2 BR 112014002404 A2 BR112014002404 A2 BR 112014002404A2 BR 112014002404 A BR112014002404 A BR 112014002404A BR 112014002404 A BR112014002404 A BR 112014002404A BR 112014002404 A2 BR112014002404 A2 BR 112014002404A2
- Authority
- BR
- Brazil
- Prior art keywords
- patient
- primer
- oligonucleotide
- kit
- probe
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1114919.2A GB201114919D0 (en) | 2011-08-30 | 2011-08-30 | Method |
PCT/EP2012/066920 WO2013030310A1 (en) | 2011-08-30 | 2012-08-30 | Detection of prame gene expression in cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112014002404A2 true BR112014002404A2 (pt) | 2017-02-21 |
Family
ID=44838891
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014002404A BR112014002404A2 (pt) | 2011-08-30 | 2012-08-30 | oligonucleotídeo, iniciador, par de iniciadores, sonda, kit, métodos para determinar se o gene prame é expressado em uma amostra biológica, de diagnose de paciente, para determinar a presença ou ausência de tecido de tumor positive, e de tratamento de um paciente, e, composição |
Country Status (14)
Country | Link |
---|---|
US (1) | US20140205635A1 (pt) |
EP (1) | EP2751282A1 (pt) |
JP (1) | JP2014527411A (pt) |
KR (1) | KR20140054399A (pt) |
CN (1) | CN103748238A (pt) |
AU (1) | AU2012300866A1 (pt) |
BR (1) | BR112014002404A2 (pt) |
CA (1) | CA2844178A1 (pt) |
EA (1) | EA201490201A1 (pt) |
GB (1) | GB201114919D0 (pt) |
IL (1) | IL230545A0 (pt) |
MX (1) | MX2014002478A (pt) |
WO (1) | WO2013030310A1 (pt) |
ZA (1) | ZA201400892B (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2824248T3 (es) | 2013-03-15 | 2021-05-11 | Myriad Genetics Inc | Genes y genes distintivos para el diagnóstico y tratamiento de melanoma |
EP4250299A3 (en) | 2014-07-02 | 2023-12-06 | Myriad myPath, LLC | Genes and gene signatures for diagnosis and treatment of melanoma |
JP7216995B2 (ja) * | 2018-12-05 | 2023-02-02 | 学校法人関西医科大学 | 胸腺癌バイオマーカー及び胸腺腫瘍の予後予測マーカー |
CN113136432A (zh) * | 2021-05-06 | 2021-07-20 | 杭州艾迪康医学检验中心有限公司 | 检测aml中prame基因相对表达量的试剂及方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE466259B (sv) | 1990-05-31 | 1992-01-20 | Arne Forsgren | Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal |
SG90042A1 (en) | 1992-06-25 | 2002-07-23 | Smithkline Beecham Biolog | Vaccine composition containing adjuvants |
GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
DE69535905D1 (de) | 1994-07-15 | 2009-02-26 | Coley Pharm Group Inc | Immunomodulatorische Oligonukleotide |
US5830753A (en) * | 1994-09-30 | 1998-11-03 | Ludwig Institute For Cancer Research | Isolated nucleic acid molecules coding for tumor rejection antigen precursor dage and uses thereof. |
UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
WO2003008537A2 (en) * | 2001-04-06 | 2003-01-30 | Mannkind Corporation | Epitope sequences |
ES2685702T3 (es) * | 2002-03-13 | 2018-10-10 | Genomic Health, Inc. | Obtención de perfil de expresión génica en tejidos tumorales biopsiados |
CA2516553C (en) * | 2003-02-20 | 2013-04-16 | Genomic Health, Inc. | Use of intronic rna to measure gene expression |
CA2529056C (en) * | 2003-06-17 | 2013-09-10 | Mannkind Corporation | Combinations of tumor-associated antigens in compositions for various types of cancers |
WO2007123772A2 (en) * | 2006-03-31 | 2007-11-01 | Genomic Health, Inc. | Genes involved in estrogen metabolism |
NZ578285A (en) * | 2007-01-15 | 2011-12-22 | Glaxosmithkline Biolog Sa | Fusion protein comprising a prame linked to a immunological fusion partner protein and additional amino acids at the n terminal end of the fusion partner sequence |
EP2171084B1 (en) * | 2007-06-01 | 2012-02-01 | Agendia B.V. | Prognostic gene expression signature for non small cell lung cancer patients |
CA2781248A1 (en) * | 2009-11-18 | 2011-05-26 | Mannkind Corporation | Monoclonal antibodies and diagnostic uses thereof |
-
2011
- 2011-08-30 GB GBGB1114919.2A patent/GB201114919D0/en not_active Ceased
-
2012
- 2012-08-30 JP JP2014527664A patent/JP2014527411A/ja active Pending
- 2012-08-30 MX MX2014002478A patent/MX2014002478A/es unknown
- 2012-08-30 KR KR1020147008390A patent/KR20140054399A/ko not_active Application Discontinuation
- 2012-08-30 EA EA201490201A patent/EA201490201A1/ru unknown
- 2012-08-30 CA CA2844178A patent/CA2844178A1/en not_active Abandoned
- 2012-08-30 AU AU2012300866A patent/AU2012300866A1/en not_active Abandoned
- 2012-08-30 WO PCT/EP2012/066920 patent/WO2013030310A1/en active Application Filing
- 2012-08-30 US US14/241,548 patent/US20140205635A1/en not_active Abandoned
- 2012-08-30 CN CN201280041090.8A patent/CN103748238A/zh active Pending
- 2012-08-30 BR BR112014002404A patent/BR112014002404A2/pt not_active IP Right Cessation
- 2012-08-30 EP EP12751532.8A patent/EP2751282A1/en not_active Withdrawn
-
2014
- 2014-01-20 IL IL230545A patent/IL230545A0/en unknown
- 2014-02-05 ZA ZA2014/00892A patent/ZA201400892B/en unknown
Also Published As
Publication number | Publication date |
---|---|
MX2014002478A (es) | 2014-07-24 |
CA2844178A1 (en) | 2013-03-07 |
KR20140054399A (ko) | 2014-05-08 |
JP2014527411A (ja) | 2014-10-16 |
IL230545A0 (en) | 2014-03-31 |
AU2012300866A1 (en) | 2014-02-27 |
CN103748238A (zh) | 2014-04-23 |
EA201490201A1 (ru) | 2014-11-28 |
ZA201400892B (en) | 2016-09-28 |
GB201114919D0 (en) | 2011-10-12 |
US20140205635A1 (en) | 2014-07-24 |
WO2013030310A1 (en) | 2013-03-07 |
EP2751282A1 (en) | 2014-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI1007321A2 (pt) | métodos para medir e/ou quantificar a presença e/ou quantidade de her-3 ou her-3 em um complexo em uma amostra de um paciente, e para determinar se um indivíduo com um câncer é provável de responder ao tratamento com uma terapia alvejada, e, anticorpo. | |
BRPI0720116B8 (pt) | método para determinar uma suscetibilidade à arritmia cardíaca ou acidente vascular cerebral em um indivíduo humano, uso de uma sonda de oligonucleotídeo, e, aparelho para determinar um indicador genético para a arritmia cardíaca e/ou acidente vascular cerebral em um indivíduo humano | |
BR112013010015A2 (pt) | aparelho e método para detecção não invasiva de doenças que afetam as propriedades estruturais em tecidos biológicos | |
BR112014009643A2 (pt) | métodos para diagnosticar ou detectar neoplasia colorretal em um sujeito humano, biomarcador para progressão de doença e kits para um diagnóstico de neoplasia colorretal | |
BR112015023783A2 (pt) | método para diagnóstico e tratamento de metastase no câncer | |
BR112012025593A2 (pt) | biomarcadores em circulação para doença | |
BR112014028625A2 (pt) | sonda pedicular endoscópica iluminada com ponta substituível | |
HK1217088A1 (zh) | 微泡在醫學疾病和病况的診斷、預後和治療中的用途 | |
MX2013000916A (es) | Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales. | |
MX2014016014A (es) | Metodos para determinar eficacia de farmacos usando proteinas asociadas a cereblon. | |
BR112015011359A2 (pt) | método para indicar uma presença ou não presença de câncer de próstata agressivo | |
BR112013020454A2 (pt) | método de diagnóstico de câncer e kit para diagnóstico usando medição de atividade de célula nk | |
BR112013012460A2 (pt) | "kit de diagnóstico para biomarcadores de benefício de saúde vaginal e método para a detecção de biomarcadoeres de benefício de saúde vaginal" | |
BR112013013898A2 (pt) | compostos de pirimidinona para o uso no tratamento de doenças ou condições mediadas por lp-pla2 | |
IT1406051B1 (it) | Uso di hmgb1 come marcatore biologico di infiammazione intestinale umana, metodo non invasivo per la sua rilevazione in campioni fecali e kit relativo. | |
EP2875158A4 (en) | USE OF MICROVESICLES IN THE DIAGNOSIS, FORECAST AND TREATMENT OF DISEASES AND MEDICAL SUDDEN | |
BR112015008255A2 (pt) | método para o diagnóstico, prognóstico e tratamento de metástase de câncer de próstata | |
BR112014031414A2 (pt) | métodos de detectar doenças ou condições utilizando células doentes circulantes | |
WO2011095894A3 (en) | Identification, assessment, and therapy of cancers with innate or acquired resistance to alk inhibitors | |
WO2014026768A8 (en) | Colorectal cancer markers | |
BR112012027151A8 (pt) | método para detectar ou identificar uma sequência de polinucleotídeo viral infeccioso ou genômico em uma célula de mamífero, tecido ou fluido biológico, método para detectar ou seguir a presença viral, replicação viral ou rearranjos genômicos virais em uma célula de mamífero, método para avaliação da eficácia de um tratamento antiviral, conjunto de sondas, kit para realizar molelular combing e materiais biológicos. | |
BR112014002404A2 (pt) | oligonucleotídeo, iniciador, par de iniciadores, sonda, kit, métodos para determinar se o gene prame é expressado em uma amostra biológica, de diagnose de paciente, para determinar a presença ou ausência de tecido de tumor positive, e de tratamento de um paciente, e, composição | |
WO2012143481A3 (en) | Prostate cancer markers | |
BR112013016107A2 (pt) | molécula dimérica, método de tratamento de câncer, composição farmacêutica e kit para o diagnóstico de uma patologia ou tumor mediado(a) por upar | |
EP2609219A4 (en) | DEFINITION OF DIAGNOSTIC AND THERAPEUTIC TARGETS OF FLOATING FREE FLOATING F TAL DNA PRESERVED IN MATERNAL BLOOD CIRCULATION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |